NMTC — Neuroone Medical Technologies Share News
0.000.00%
- $6.78m
- $4.74m
- $12.10m
Brief: Neuroone® Submits Special 510(K) To FDA For Evo® Seeg Electrode
Brief: Neuroone Announces First Clinical Case Using Evo Seeg Electrode
Brief: NeuroOne Provides Evo sEEG Update
Neuroone Medical Technologies Corp reports results for the quarter ended in March - Earnings Summary
Brief: Neuroone Reports Q2 Fiscal Year 2022 Results And Provides Corporate Update
Neuroone Medical Technologies Corp expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Verastem, Nio, metal miners
U.S. STOCKS ON THE MOVE-DatChat Inc, HP Inc, Natural gas firms
Neuroone Medical Technologies plunges after FDA denies its application
Brief: Neuroone Medical FDA Had Denied Co's 510(K) Clearance Application For Use Of Evo Seeg Electrode Technology
Neuroone Medical Technologies Corp reports results for the quarter ended in December - Earnings Summary
Brief: NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results And Provides Corporate Update
Brief: Neuroone Reports Fourth Fiscal Quarter And Full Fiscal Year 2021 Financial Results And Provides Corporate Update
Neuroone Medical Technologies Corp expected to post a loss of 23 cents a share - Earnings Preview
NeuroOne Medical dives on deep-discounted stock offering
Brief: Neuroone Medical Technologies Corp Announces Pricing Of Public Offering Of Common Stock
Brief: Neuroone Medical Technologies Corporation Announces Proposed Public Offering Of Common Stock
NASDAQ RESUMED AT 09:41 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM